SEC Form 4 · accession 0001213900-26-085710
Tiziana Life Sciences Ltd · TLSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ivor Elrifi
Officer — Chief Executive Officer
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001723069
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Aug 3, 2026 | P | 667,000 | $1.00 | A | 4,472,261 | I | By trust |
Table II — derivative securities
No Table II lines on this filing.